P2.12-03 COVALENT-102: A Phase 1/1b Study of BMF-219, A Menin Inhibitor in Patients with Unresectable, Metastatic NSCLC, PDAC, and CRC
| Autor: | Patel, S., Hong, D., Cohen, S.A., Fountzilas, C., Sommerhalder, D., Radhi, S., Benson, A., He, K., Pisick, E., Bessudo, A., Duvivier, H., Tong, T., Munneke, B., Kosaka, Y., Ahmed, U., Cacovean, A., Morris, S., Butler, T., Spira, A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2023 18(11) Supplement:S363-S363 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|